Genome-wide linkage and sequence analysis challenge CCDC66 as a human retinal dystrophy candidate gene and support a distinct NMNAT1-related fundus phenotype.
Arif O KhanB S BuddeP NürnbergA KawaliaS LenznerH J BolzPublished in: Clinical genetics (2017)
To uncover the genotype underlying early-onset cone-rod dystrophy and central nummular macular atrophic lesion in 2 siblings from an endogamous Arab family, we performed targeted next-generation sequencing (NGS) of 44 retinal dystrophy genes, whole-exome sequencing (WES) and genome-wide linkage analysis. Targeted NGS and WES in the index patient highlighted 2 homozygous variants, a CCDC66 frameshift deletion and a novel missense NMNAT1 variant, c.500G>A (p.Asn167Ser). Linkage and segregation analysis excluded the CCDC66 variant and confirmed the NMNAT1 mutation. Biallelic NMNAT1 mutations cause Leber congenital amaurosis with a central nummular macular atrophic lesion (LCA9). The NMNAT1 mutation reported here underlied cone-rod dystrophy rather than LCA but the fundus lesion was compatible with that of LCA9 patients, highlighting that such a fundus appearance should raise suspicion for biallelic mutations in NMNAT1 when in the context of any retinal dystrophy. Although Ccdc66 mutations have been proposed to cause retinal disease in dogs, our results and public databases challenge CCDC66 as a candidate gene for human retinal dystrophy.
Keyphrases
- early onset
- genome wide
- diabetic retinopathy
- optical coherence tomography
- copy number
- dna methylation
- late onset
- endothelial cells
- intellectual disability
- end stage renal disease
- optic nerve
- gene expression
- healthcare
- peritoneal dialysis
- cancer therapy
- artificial intelligence
- chronic kidney disease
- mental health
- induced pluripotent stem cells
- hepatitis c virus
- hiv testing
- machine learning
- patient reported outcomes
- deep learning
- drug delivery
- circulating tumor cells